RNS-60 by Revalesio for Acute Ischemic Stroke: Likelihood of Approval

RNS-60 is under clinical development by Revalesio and currently in Phase II for Acute Ischemic Stroke.

Study reveals doubling of chronic hypertension in pregnancy from 2008 to 2021 in the U. S.

The number of individuals in the U.S. who had chronic hypertension or chronic high blood pressure during pregnancy doubled between 2008 and 2021, while the

June 17, 2024

Updated: Viridian reveals first Phase 3 eye disease data in bid to compete with Tepezza

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

RNS-60 by Revalesio for Acute Ischemic Stroke: Likelihood of Approval

ECOG-ACRIN launches new trial to evaluate nilotinib and paclitaxel for advanced cancers

Study reveals doubling of chronic hypertension in pregnancy from 2008 to 2021 in the U. S.

Updated: Viridian reveals first Phase 3 eye disease data in bid to compete with Tepezza

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe